-
Something wrong with this record ?
Piperazine derivatives for therapeutic use: a patent review (2010-present)
AK. Rathi, R. Syed, HS. Shin, RV. Patel,
Language English Country England, Great Britain
Document type Journal Article, Review
- MeSH
- Humans MeSH
- Drug Discovery methods MeSH
- Patents as Topic MeSH
- Piperazines chemistry pharmacology therapeutic use MeSH
- Drug Design * MeSH
- Structure-Activity Relationship MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
INTRODUCTION: Piperazine, a six membered nitrogen containing heterocycle, is of great significance to the rational design of drugs. This moiety can be found in a plethora of well-known drugs with various therapeutic uses, such as antipsychotic, antihistamine, antianginal, antidepressant, anticancer, antiviral, cardio protectors, anti-inflammatory, and imaging agents. Slight modification to the substitution pattern on the piperazine nucleus facilitates a recognizable difference in the medicinal potential of the resultant molecules. AREAS COVERED: Scifinder was the main source used to search for patents containing piperazine compounds with therapeutic uses. The article describes a variety of molecular designs bearing piperazine entity furnishing CNS agents, anticancer, cardio-protective agents, antiviral, anti-tuberculosis, anti-inflammatory, antidiabetic, and antihistamine profiles, as well as agents relieving pain and useful in imaging applications. EXPERT OPINION: The great interest gathered to explore piperazine based molecules in relatively few years reflects the broad potential of the entity. Earlier, this scaffold was considered to express CNS activity only. However, a significant increase in research covering studies of several different activities of piperazine ring suggest a successful emergence of the pharmacophore. Certain patents outlined in the present article recommend that piperazines can be a flexible building block to discover drug-like elements and modification of substituents present on the piperazine ring may have a significant impact on the pharmacokinetic and pharmacodynamics factors of the resulting molecules. This article aims to provide insights to piperazine based molecular fragments that would assist drug discoverers to rationally design molecules for various diseases. We anticipate, and highly recommend, further therapeutic investigations on this motif.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17013859
- 003
- CZ-PrNML
- 005
- 20170502093412.0
- 007
- ta
- 008
- 170413s2016 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/13543776.2016.1189902 $2 doi
- 035 __
- $a (PubMed)27177234
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Rathi, Anuj K $u a Regional Centre of Advanced Technologies and Materials, Faculty of Science, Department of Physical Chemistry , Palacky University , Olomouc , Czech Republic.
- 245 10
- $a Piperazine derivatives for therapeutic use: a patent review (2010-present) / $c AK. Rathi, R. Syed, HS. Shin, RV. Patel,
- 520 9_
- $a INTRODUCTION: Piperazine, a six membered nitrogen containing heterocycle, is of great significance to the rational design of drugs. This moiety can be found in a plethora of well-known drugs with various therapeutic uses, such as antipsychotic, antihistamine, antianginal, antidepressant, anticancer, antiviral, cardio protectors, anti-inflammatory, and imaging agents. Slight modification to the substitution pattern on the piperazine nucleus facilitates a recognizable difference in the medicinal potential of the resultant molecules. AREAS COVERED: Scifinder was the main source used to search for patents containing piperazine compounds with therapeutic uses. The article describes a variety of molecular designs bearing piperazine entity furnishing CNS agents, anticancer, cardio-protective agents, antiviral, anti-tuberculosis, anti-inflammatory, antidiabetic, and antihistamine profiles, as well as agents relieving pain and useful in imaging applications. EXPERT OPINION: The great interest gathered to explore piperazine based molecules in relatively few years reflects the broad potential of the entity. Earlier, this scaffold was considered to express CNS activity only. However, a significant increase in research covering studies of several different activities of piperazine ring suggest a successful emergence of the pharmacophore. Certain patents outlined in the present article recommend that piperazines can be a flexible building block to discover drug-like elements and modification of substituents present on the piperazine ring may have a significant impact on the pharmacokinetic and pharmacodynamics factors of the resulting molecules. This article aims to provide insights to piperazine based molecular fragments that would assist drug discoverers to rationally design molecules for various diseases. We anticipate, and highly recommend, further therapeutic investigations on this motif.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a racionální návrh léčiv $7 D015195
- 650 _2
- $a objevování léků $x metody $7 D055808
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a patenty jako téma $7 D010330
- 650 _2
- $a piperaziny $x chemie $x farmakologie $x terapeutické užití $7 D010879
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Syed, Riyaz $u b Department of Chemistry , J.N.T. University , Hyderabad , India.
- 700 1_
- $a Shin, Han-Seung $u c Department of Food Science and Biotechnology, School of Life Science and Biotechnology , Dongguk University , Goyang-si , Republic of Korea.
- 700 1_
- $a Patel, Rahul V $u c Department of Food Science and Biotechnology, School of Life Science and Biotechnology , Dongguk University , Goyang-si , Republic of Korea.
- 773 0_
- $w MED00181402 $t Expert opinion on therapeutic patents $x 1744-7674 $g Roč. 26, č. 7 (2016), s. 777-97
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27177234 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20170502093739 $b ABA008
- 999 __
- $a ok $b bmc $g 1200324 $s 974637
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 26 $c 7 $d 777-97 $e 20160531 $i 1744-7674 $m Expert opinion on therapeutic patents $n Expert Opin Ther Pat $x MED00181402
- LZP __
- $a Pubmed-20170413